Ilene Wiggins, RN

CRS:

JHU

Role:

Clinical

Position:

Senior Research Nurse Program Manager for the Johns Hopkins CTU

Email:

iwiggin1@jhmi.edu

As CTU/CRS Coordinator/Research Manager, Ms. Wiggins is responsible for the day-to-day operations of the CTU with respect to domestic (U.S.) research activities. Ms. Wiggins has been a nurse coordinator for the Johns Hopkins AIDS Clinical Trials Unit (ACTU) for more than 20 years, and has been Research Manager/Coordinator for this Unit since 2002. In this role, she works closely with the PI’s, CRS Leaders and investigators to plan and execute the CTU’s scientific activities.

  • Chair, Site Management and Clinical Care Committee (Dec 2016)
  • SMCCC Representative, Protocol Development and implementation Subcommittee of the SMCCC (Dec 2015)
  • SMCCC Representative, Site Operations Subcommittee of the SMCCC (Dec 2016)
  • SMCCC Representative, Training and Education Working Group of the SOS (Dec 2015)
  • Member, Study Coordinators Working Group of the SOS (Jun 2011)

Categories

Leadership Committees
CRS
Roles

Clinical Trials

P2001 (DAIDS ID 12026): Evaluating the Pharmacokinetics,...

TB is a major cause of illness and death in women of reproductive age. Pregnant and postpartum women with latent TB are at...

Read More

A5342: Evaluating the Safety, Tolerability, and Effect of a...

The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...

Read More

HPTN083: A Phase 2b/3 Double Blind Safety and Efficacy Study...

HPTN 083 is a study being done to evaluate the efficacy of the long-acting injectable agent, cabotegravir (CAB LA), for...

Read More

A5349: Rifapentine-containing treatment shortening regimens...

The purpose of this study is to determine whether one or two four-month regimens of tuberculosis treatment are as effective as a...

Read More

P1108: A Phase I/II, Open-Label, Single Arm Study to...

This purpose of this study is to evaluate the pharmacokinetics (PK), safety, and tolerability of bedaquiline (BDQ) in...

Read More